Your browser doesn't support javascript.
loading
Granzyme K initiates IL-6 and IL-8 release from epithelial cells by activating protease-activated receptor 2.
Kaiserman, Dion; Zhao, Peishen; Rowe, Caitlin Lorraine; Leong, Andrea; Barlow, Nicholas; Joeckel, Lars Thomas; Hitchen, Corinne; Stewart, Sarah Elizabeth; Hollenberg, Morley D; Bunnett, Nigel; Suhrbier, Andreas; Bird, Phillip Ian.
Affiliation
  • Kaiserman D; Department of Biochemistry & Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Zhao P; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Rowe CL; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, VIC, Australia.
  • Leong A; Department of Biochemistry & Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Barlow N; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Joeckel LT; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, VIC, Australia.
  • Hitchen C; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Stewart SE; Department of Biochemistry & Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Hollenberg MD; Department of Biochemistry & Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Bunnett N; Department of Biochemistry & Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Suhrbier A; Department of Physiology & Pharmacology, Department of Medicine, University of Calgary, Calgary AB, Canada.
  • Bird PI; Department of Molecular Pathobiology, Department of Neuroscience and Physiology, Neuroscience Institute, New York University, New York, NY, United States of America.
PLoS One ; 17(7): e0270584, 2022.
Article in En | MEDLINE | ID: mdl-35881628
ABSTRACT
Granzyme K (GzmK) is a tryptic member of the granzyme family of chymotrypsin-like serine proteases produced by cells of the immune system. Previous studies have indicated that GzmK activates protease-activated receptor 1 (PAR1) enhancing activation of monocytes and wound healing in endothelial cells. Here, we show using peptides and full length proteins that GzmK and, to a lesser extent the related protease GzmA, are capable of activating PAR1 and PAR2. These cleavage events occur at the canonical arginine P1 residue and involve exosite interactions between protease and receptor. Despite cleaving PAR2 at the same point as trypsin, GzmK does not induce a classical Ca2+ flux but instead activates a distinct signalling cascade, involving recruitment of ß-arrestin and phosphorylation of ERK. In epithelial A549 cells, PAR2 activation by GzmK results in the release of inflammatory cytokines IL-6 and IL-8. These data suggest that during an immune response GzmK acts as a pro-inflammatory regulator, rather than as a cytotoxin.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, PAR-1 / Receptor, PAR-2 Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, PAR-1 / Receptor, PAR-2 Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Australia
...